← Back to Search

Atherectomy Device

Atherectomy for Peripheral Arterial Disease

N/A

Waitlist Available

Research Sponsored by Ra Medical Systems

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is testing whether a laser system is safe and effective for treating peripheral vascular stenoses (narrowing of blood vessels).

Eligible Conditions

Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Freedom from Major Adverse Events (MAE)

Technical Success

Secondary outcome measures

Change in Percent Diameter Stenosis

Incidence of Target Lesion Revascularization (TLR) at 6 months

Reduction in Residual Diameter Stenosis

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Excimer Laser PhotoablationExperimental Treatment1 Intervention

Device: DABRA Laser System Patients with symptomatic peripheral vascular disease undergoing an endovascular revascularization procedure utilizing the DABRA Laser System.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Atherectomy

2020

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ra Medical SystemsLead Sponsor

2 Previous Clinical Trials

83 Total Patients Enrolled

2 Trials studying Peripheral Arterial Disease

83 Patients Enrolled for Peripheral Arterial Disease

Athar Ansari, MDStudy Chair

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the desired outcomes of this experiment?

"The primary aim of this research project is to determine freedom from major adverse events (MAE). Other metrics, such as changes in percent diameter stenosis, incidence of target lesion revascularization at 6 months, and Rutherford Classification will also be evaluated."

Answered by AI

Are there any current opportunities to enroll in this clinical experiment?

"According to the clinicaltrials.gov platform, this particular medical trial is currently not seeking participants and has been inactive since November 1st 2022. Nevertheless, 216 other trials are actively recruiting patients at present."

Answered by AI

How many healthcare facilities have implemented this research endeavor?

"Currently, the trial is running in a total of 9 different cities. These include Chicago, Merced and Gainesville as well other nearby locales, so it may be prudent to pick the nearest site to you when enrolling in order to reduce travel burdens."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages

2020. "A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04241224.